Shopping Cart
- Remove All
- Your shopping cart is currently empty
MK-2206 is an orally active, highly selective, metabotropic Akt inhibitor that targets Akt1 [IC50: 8 nM], Akt2 [IC50: 12 nM], and Akt3 [IC50: 65 nM]. Many breast cancer cell lines, PIK3CA mutants, and PTEN-losing cell lines are sensitive to MK-2206, which exhibits anti-cancer effects.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $2,140 | 1-2 weeks | |
50 mg | $2,785 | 1-2 weeks | |
100 mg | $3,520 | 1-2 weeks |
Description | MK-2206 is an orally active, highly selective, metabotropic Akt inhibitor that targets Akt1 [IC50: 8 nM], Akt2 [IC50: 12 nM], and Akt3 [IC50: 65 nM]. Many breast cancer cell lines, PIK3CA mutants, and PTEN-losing cell lines are sensitive to MK-2206, which exhibits anti-cancer effects. |
Alias | MK-2206 Monohydrochloride |
Molecular Weight | 443.94 |
Formula | C25H22ClN5O |
Cas No. | 1032349-77-1 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.